Detalhe da pesquisa
1.
Preclinical Evaluation of the FGFR-Family Inhibitor Futibatinib for Pediatric Rhabdomyosarcoma.
Cancers (Basel)
; 15(16)2023 Aug 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37627061
2.
Preclinical development of a chimeric antigen receptor T cell therapy targeting FGFR4 in rhabdomyosarcoma.
Cell Rep Med
; 4(10): 101212, 2023 10 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37774704
3.
Differential Impacts of HHV-6A versus HHV-6B Infection in Differentiated Human Neural Stem Cells.
Front Immunol
; 13: 847106, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35911725
4.
An optimized bicistronic chimeric antigen receptor against GPC2 or CD276 overcomes heterogeneous expression in neuroblastoma.
J Clin Invest
; 132(16)2022 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35852863
5.
Preclinical development of a chimeric antigen receptor T cell therapy targeting FGFR4 in rhabdomyosarcoma.
Cell Rep Med
; 5(5): 101586, 2024 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38723625